M&A

Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M
Fierce Pharma
Thu, 04/11/24 - 11:31 am
Pfizer
legal
Wyeth
M&A
pay-for-delay
antitrust
Vertex to buy kidney disease drugmaker Alpine for $4.9B
BioPharma Dive
Wed, 04/10/24 - 06:05 pm
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
IgA nephropathy
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
For biopharma M&A, the best returns come from small deals: analysts
Fierce Pharma
Tue, 04/9/24 - 11:14 am
M&A
Bristol Myers Squibb
AbbVie
A Drowning Medtech Company Clings to a Life Preserver
Medical Devices and Diagnostics Industry
Tue, 04/9/24 - 11:08 am
Medtech
robotic surgery
Asensus Surgical
Karl Storz
M&A
J&J scoops up cardio medtech Shockwave Medical for $13.1B
Medical Marketing and Media
Fri, 04/5/24 - 11:54 am
JNJ
M&A
Medtech
Shockwave Medical
Cardiovascular
intravascular lithotripsy
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
BioSpace
Fri, 04/5/24 - 11:52 am
Novo Nordisk
M&A
Catalent
SEC
FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal
Reuters
Thu, 04/4/24 - 10:57 am
Boston Scientific
Medtech
FTC
M&A
Axonics
Paragon’s hub-and-spoke biotech model yields another reverse merger
BioPharma Dive
Wed, 04/3/24 - 10:24 pm
Oruka Therapeutics
skin diseases
ARCA biopharma
M&A
Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition
BioSpace
Wed, 04/3/24 - 11:38 am
Genmab
M&A
ProfoundBio
antibody-drug conjugate
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Novo’s $1.1B Cardior buy continues expansion into heart disease
BioSpace
Mon, 03/25/24 - 11:39 am
Novo Nordisk
Cardior Pharmaceuticals
M&A
heart disease
AbbVie to bolster immunity illness drug pipeline with Landos buy
Yahoo/Reuters
Mon, 03/25/24 - 11:39 am
AbbVie
Landos Biopharma
immune disorders
M&A
A year after the acquisition of Bellus Health, GSK planning to let go of most former Bellus employees
LinkedIn
Fri, 03/22/24 - 10:50 am
GSK
Bellus Health
M&A
layoffs
EU adviser says Illumina merger was not problematic
Stat
Fri, 03/22/24 - 09:33 am
Illumina
Grail
M&A
Europe
Elevance to buy Kroger’s specialty pharmacy
BioPharma Dive
Wed, 03/20/24 - 11:42 am
Elevance Health
PBMs
Kroger
specialty pharmacies
M&A
AstraZeneca scoops up Fusion Pharmaceuticals in $2.4B radiopharma deal
Medical Marketing and Media
Tue, 03/19/24 - 11:58 am
AstraZeneca
Fusion Pharmaceuticals
M&A
radiopharmaceuticals
Eliem cuts in on Tango, proposing acquisition after strategic review
Fierce Biotech
Tue, 03/19/24 - 11:51 am
Eliem Therapeutics
Tango Therapeutics
M&A
oncology
After Kyowa Kirin buyout, Orchard scores FDA approval for first MLD gene therapy in the US
Fierce Pharma
Mon, 03/18/24 - 05:16 pm
Orchard Therapeutics
Kyowa Kirin
M&A
Lenmeldy
FDA
metachromatic leukodystrophy
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
M&A
Bristol Myers Squibb
Novartis
AstraZeneca
Novo Nordisk
Pfizer

Pages